Pathogenetic therapy in patients with COVID-19
The new coronavirus infection (COVID-19) has become a truly global challenge for all of humanity, and, above all, for the healthcare system. Among its most important aspects that require careful analysis are the clinical and laboratory features of the course of the disease, which make it possible to...
Saved in:
Main Authors: | V. A. Kapatsina, M. A. Vashukova, D. A. Gusev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Journal Infectology
2022-10-01
|
Series: | Журнал инфектологии |
Subjects: | |
Online Access: | https://journal.niidi.ru/jofin/article/view/1394 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with the use of recombinant humanized monoclonal antibodies to the human receptor for interleukin-6 in patients with CoVID-19
by: D. А. Gusev, et al.
Published: (2020-08-01) -
Issues of pathology of a new coronavirus infection CoVID-19
by: V. A. Zinserling, et al.
Published: (2020-06-01) -
Clinical and pathological analysis of deaths from different SARS-CoV-2 coronavirus genotypes
by: M. A. Vashukova, et al.
Published: (2022-10-01) -
Respiratory Syncytial Virus Infection. Pathogenesis Peculiarities, Prevention and Treatment Strategies
by: V. Z. Krivitskaya
Published: (2013-03-01) -
Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic
by: V. N. Yakimets, et al.
Published: (2024-01-01)